Company Profile

ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. We uniquely provide both established clinical products as well as pre-clinical development services for controlled drug and device delivery. ClearPoint Neuro is engaged with healthcare and research centers in North America, Europe, Asia, and South America.

Latest News

View All News
View All News

Latest Financial Results

Q1 2025

Quarter Ended Mar 31, 2025
Earnings Release
PDF HTML
Earnings Webcast
Audio
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2024

Report Links

Company Overview

ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. We uniquely provide both established clinical products as well as pre-clinical development services for controlled drug and device delivery. ClearPoint Neuro is engaged with healthcare and research centers in North America, Europe, Asia, and South America.

View Company Info

Leadership

View Management Team View Board of Directors

Investor Contact Information

Investor Relations

ClearPoint Neuro
Danilo D'Alessandro
ir@clearpointneuro.com

Transfer Agent

Continental Stock Transfer & Trust Company
One State Street Plaza
30th Floor
New York, NY 10004
T: 212-509-4000
F: 212-509-5150
https://continentalstock.com